Organika Health Products Inc. Bromelain Tablets
Organika Health Products Inc. Bromelain Tablets, NPN 80033205: natural health product licensed in Canada. Medicinal ingredients: Bromélaïne de tige.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bromélaïne de tige Source : Ananas comosus - Tige | 7,200,000 FCC PU | Not calculated |
| Bromélaïne de tige Source : Ananas comosus - Tige | 600 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose, microcristalline, phosphate de dicalcium, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Digestive enzyme.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Known Adverse Reactions
Hypersensitivity/allergy has been known to occur, in which case, discontinue use. Nausea, vomiting, and diarrhea have been known to occur, in which case, discontinue use (and consult a health care practitioner).
- Cautions and Warnings
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have gastrointestinal lesions/ulcers, are taking anticoagulant agents, anti-inflammatory agents or antibiotics or before having surgery.
Product record
- Licence holder
- Organika Health Products Inc.
- NPN or DIN-HM
- 80033205
- Status
- Active licence
- Licence date
- 28 June 2012
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80033205
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Organika Health Products Inc. Bromelain Tablets: composition and ingredients”, https://compoatlas.com/en/supplements/canada/80033205-organika-health-products-inc-bromelain-tablets, updated 28 June 2012.